Company: HROW
Filing Date: 2025-08-11
Form Type: 10-Q
Source: 0001641172-25-022980
Chunk: 8

Company: HARROW, INC.
Filing Date: 2025-08-11
Form: 10-Q
Item: Item 1
Chunk 8
---
 of property, plant and equipment and software development costs 
     961,000  
     885,000 
  
    Amortization of intangible assets 
     8,452,000  
     5,103,000 
  
    Amortization of operating lease right-of-use assets 
     399,000  
     392,000 
  
    Provision for (recovery of) credit losses 
     340,000  
     (96,000)
  
    Amortization of debt issuance costs and debt discount 
     2,564,000  
     1,951,000 
  
    Investment loss from investment in Eton Pharmaceuticals 
     -  
     3,171,000 
  
    Stock-based compensation 
     5,431,000  
     8,440,000 
  
    Deferred income tax 
     -  
     623,000 
  
    Changes in assets and liabilities: 

    Accounts receivable 
     37,211,000  
     (15,631,000)
  
    Inventories 
     (850,000) 
     1,442,000 
  
    Prepaid expenses and other current assets 
     3,776,000  
     2,579,000 
  
    Accounts payable, accrued expenses, accrued rebates and copay assistance 
     (24,009,000) 
     3,361,000 
  
    Accrued payroll and related liabilities 
     (2,672,000) 
     271,000 
  
    Deferred revenue and customer deposits 
     47,000  
     173,000 
  
    NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 
     18,865,000  
     (7,374,000)
  
    CASH FLOWS FROM INVESTING ACTIVITIES 

    Net proceeds on sale of investment in Eton Pharmaceuticals 
     -  
     5,510,000 
  
    Investment in patent and trademark assets 
     (169,000) 
     (81,000)
  
    Purchases of property, plant and equipment 
     (336,000) 
     (436,000)
  
    NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES 
     (505,000)